Dynamic changes in the gut microbiota during three consecutive trimesters of pregnancy and their correlation with abnormal glucose and lipid metabolism

• Published in: European journal of medical research Vol. 29; no. 1; pp. 117 - 18
• Main Authors: Gao, Yiyang, Zhang, Jinjia, Chen, Haiying, Jin, Xiaohui, Lin, Zhenyu, Fan, Chenling, Shan, Zhongyan, Teng, Weiping, Li, Jing
• Format: Journal Article
• Language: English
• Published: London BioMed Central 12.02.2024; BioMed Central Ltd; BMC
• Subjects: Analysis; Bacteria; Biomedicine; Blood sugar; Cholesterol; Diabetes; Feces; Glucose; Glucose and lipid metabolism; Glucose metabolism; Gut microbiota; High density lipoprotein; Immunoassay; Immunology; Infectious Diseases; Internal Medicine; Lipids; Lipoproteins; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Metabolic disorders; Metabolism; Metabolites; Microbiota; Microbiota (Symbiotic organisms); Oncology; Physiological aspects; Physiology; Pregnancy; Pregnant women; Questionnaires; Statistical analysis; Surgery; Thyroid gland; Womens health; United States > US; Switzerland; China; Pregnancy; Gut microbiota; Glucose and lipid metabolism
• ISSN: 2047-783X; 0949-2321; 2047-783X
• DOI: 10.1186/s40001-024-01702-0

Introduction During normal pregnancy, changes in the gut microbiota (GM) in response to physiological alterations in hormonal secretion, immune functions and homeostasis have received extensive attention. However, the dynamic changes in the GM during three consecutive trimesters of pregnancy and their relationship with glucose and lipid metabolism have not been reported. In this study, we aimed to investigate the dynamic changes in the diversity and species of the GM during three consecutive trimesters in women who naturally conceived, and their relationships with abnormal fasting blood glucose (FBG) and serum lipid levels. Methods A total of 30 pregnant women without any known chronic or autoimmune inflammatory disease history before pregnancy were enrolled during the first trimester. Serum and stool samples were collected during the first trimester, the second trimester, and the third trimester. Serum samples were tested for FBG and blood lipid levels, and stool specimens were analyzed by 16S rDNA sequencing. Results The abundance ratio of bacteroidetes/firmicutes showed an increasing tendency in most of the subjects (19/30, 63.3%) from the first to the third trimester. LEfSe analysis showed that the abundance of Bilophila was significantly increased from the first to the third trimester. In addition, at the genus level, the increased relative abundance of Mitsuokella , Clostridium sensu stricto and Weissella were potentially involved in the development of high FBG during pregnancy. The raised relative abundance of Corynebacterium , Rothia and Granulicatella potentially contributed to the occurrence of dyslipidemia during pregnancy. Conclusions There are dynamic changes in the GM during the three trimesters, and the alterations in some bacterium abundance may contribute to the development of high FBG and dyslipidemia during pregnancy. Monitoring enterotypes and correcting dysbiosis in the first trimester may become new strategies for predicting and preventing glucolipid metabolism disorders during pregnancy.